ADNRX Mutual Fund
ADNRX Mutual Fund
ADNRX Mutual Fund
American Beacon ARK Transformational Innovation Fund Class R6
ADNRX Mutual Fund Overview
ADNRX Mutual Fund (American Beacon ARK Transformational Innovation Fund Class R6) is managed by American Beacon Funds. ADNRX expense ratio is 1.05%, holding 47 positions across sectors including Information Technology, Health Care, Consumer Discretionary. Inception date: 2020-10-28.
ADNRX performance shows a YTD return of 13.86%. The 1-year return is 17.01% and the 5-year return is -5.51%.
ADNRX top holdings include Tesla Inc (9.8%), Tempus Pe (5.9%), Space Exploration Technologies (5.0%), Crispr Therapeutics Ag Common Stock Chf.03 (4.8%), Coinbase Globa-A (4.7%). Go to all ADNRX holdings, ADNRX sectors, or ADNRX dividends.
ADNRX can be compared against other funds. Use ADNRX overlap to find shared positions, or ADNRX vs another fund for a side-by-side view. ADNRX alternatives are available via the screener, along with tax-loss harvesting opportunities.